New Clinical Implications of Opiate Maintenance Treatments

authors:

avatar Gonzalo Haro 1 , *

Program of Dual Pathology. Hospital Provincial University, Castellon, Spain

how to cite: Haro G. New Clinical Implications of Opiate Maintenance Treatments. Int J High Risk Behav Addict. 2012;1(2): 88-89. https://doi.org/10.5812/ijhrba.6532.

References

  • 1.

    Haro G, Martinez-Raga J, Castellano M, Bolinches F, de Vicente P, Valderrama JC. [Heroin prescribing: Is there scientific evidence of its efficacy for the treatment of its dependence?]. Actas Esp Psiquiatr. 2001;29(5):343-8. [PubMed ID: 11602093].

  • 2.

    McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269(15):1953-9. [PubMed ID: 8385230]. https://doi.org/10.1001/jama.269.15.1953.

  • 3.

    Zylicz Z. Opioidinduced hypogonadism: the role of androgens in the wellbeing and pain thresholds in men and women with advanced disease. J Adv in Palliative Med. 2009;8(2):57-62.

  • 4.

    Kolar AF, Brown BS, Weddington WW, Ball JC. A treatment crisis: cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat. 1990;7(2):101-7. https://doi.org/10.1016/0740-5472(90)90005-B.

  • 5.

    Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F. A Quantitative and Qualitative Study of Rat Testis Following Administration of Methadone and Buprenorphine. Int J High Risk Behav Addict. 2012;1(1):12-5. https://doi.org/10.5812/ijhrba.4119.

  • 6.

    Benito A, Haro G, Orengo T, Gonzalez M, Fornes T, Mateu C. [Opiate Dependence Type II or antisocial: Cloningers Psychobiological Model and its usefullness in addictions]. Adicciones. 2012;24(2):131-8. [PubMed ID: 22648316].